Skip to content
Clinical Trials – home
Nektar Therapeutics
Sponsor

Nektar Therapeutics

United States 455 Mission Bay Boulevard South, 94158-2158, United States

About the sponsor

Nektar Therapeutics is involved in clinical research for alopecia areata, with a focus on severe to very severe disease and the restoration of scalp hair growth.

  • Severe alopecia areata
  • Hair loss reduction
  • Immune-mediated follicle disease

This area reflects interest in therapies aimed at modifying the underlying immune dysregulation associated with patchy and extensive hair loss.

About Specializations

Nektar Therapeutics runs clinical trials in conditions such as Dermatitis atopic, Alopecia areata, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Dermatitis atopic

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Alopecia areata

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.